Complex gene–gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes

The complex inheritance involved in multiple sclerosis (MS) risk has been extensively investigated, but our understanding of MS genetics remains rudimentary. In this study, we explore 51 single nucleotide polymorphisms (SNPs) in 36 candidate genes from the inflammatory pathway and test for gene–gene interactions using complementary case–control, discordant sibling pair, and trio family study designs. We used a sample of 421 carefully diagnosed MS cases and 96 unrelated, healthy controls; discordant sibling pairs from 146 multiplex families; and 275 trio families. We used multifactor dimensionality reduction to explore gene–gene interactions. Based on our analyses, we have identified several statistically significant models including both main effect models and two-locus, three-locus, and four-locus epistasis models that predict MS disease risk with between ∼61% and 85% accuracy. These results suggest that significant epistasis, or gene–gene interactions, may exist even in the absence of statistically significant individual main effects.

[1]  A. Consiglio,et al.  Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis , 1997, Journal of Neuroimmunology.

[2]  J. Ward,et al.  Insight into the Physiological Function(s) of Uteroglobin by Gene‐Knockout and Antisense‐Transgenic Approaches , 2000, Annals of the New York Academy of Sciences.

[3]  J. Haines,et al.  HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. , 2003, American journal of human genetics.

[4]  B. Chorley,et al.  (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. , 2006, American journal of respiratory cell and molecular biology.

[5]  J. Haines,et al.  Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. , 1998, Human molecular genetics.

[6]  R. Sobel,et al.  Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions , 2005, Journal of Neuroimmunology.

[7]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[8]  J. Haines,et al.  Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44 , 2006, Genes and Immunity.

[9]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[10]  M. Babron,et al.  Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach , 2000, Journal of Neuroimmunology.

[11]  C. Porsbjerg,et al.  Association between asthma-related phenotypes and the CC16 A38G polymorphism in an unselected population of young adult Danes , 2005, Immunogenetics.

[12]  Chien‐Ho Chen,et al.  Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein. , 2004, The Journal of allergy and clinical immunology.

[13]  Pierre J. Vinken,et al.  Multiple Sclerosis and Other Demyelinating Diseases , 1970 .

[14]  J. H. Moore,et al.  A novel method to identify gene–gene effects in nuclear families: the MDR‐PDT , 2006, Genetic epidemiology.

[15]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[16]  J. Haines,et al.  Genetic basis for clinical expression in multiple sclerosis. , 2002, Brain : a journal of neurology.

[17]  G. Silverman,et al.  Uteroglobin Suppresses SCCA Gene Expression Associated with Allergic Asthma* , 2005, Journal of Biological Chemistry.

[18]  R. Bellman,et al.  V. Adaptive Control Processes , 1964 .

[19]  J. Concato,et al.  The Risk of Determining Risk with Multivariable Models , 1993, Annals of Internal Medicine.

[20]  S. Peters,et al.  Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. , 2006, Blood.

[21]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[22]  David Reich,et al.  A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility , 2005, Nature Genetics.

[23]  G. Ebers.  Modelling multiple sclerosis , 1999, Nature Genetics.

[24]  Yue Sun,et al.  Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways , 2004 .

[25]  G. McDonnell,et al.  An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis , 2000, Journal of the Neurological Sciences.

[26]  M. Daly,et al.  A high-density screen for linkage in multiple sclerosis. , 2005, American journal of human genetics.

[27]  Foster J. Provost,et al.  Learning When Training Data are Costly: The Effect of Class Distribution on Tree Induction , 2003, J. Artif. Intell. Res..

[28]  Vittorio Modena,et al.  Polymorphism of the Uteroglobin Gene in Systemic Lupus Erythematosus and IgA Nephropathy , 2002, Laboratory Investigation.

[29]  Nathalie Japkowicz,et al.  The class imbalance problem: A systematic study , 2002, Intell. Data Anal..

[30]  J L Haines,et al.  Multifactor dimensionality reduction reveals gene–gene interactions associated with multiple sclerosis susceptibility in African Americans , 2006, Genes and Immunity.

[31]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[32]  Jason H. Moore,et al.  Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions , 2003, Bioinform..

[33]  Cynthia S Crowson,et al.  Prognostic markers of radiographic progression in early rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[34]  Yue Sun,et al.  Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. , 2004, Molecular cell.

[35]  J. Oksenberg,et al.  Multiple sclerosis genetics: leaving no stone unturned , 2005, Genes and Immunity.

[36]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[37]  T. Loop,et al.  Dobutamine Inhibits Phorbol-Myristate-Acetate-Induced Activation of Nuclear Factor-&kgr;B in Human T Lymphocytes In Vitro , 2004, Anesthesia and analgesia.

[38]  M. Wade,et al.  Epistasis and the Evolutionary Process , 2000 .

[39]  J. Haines,et al.  Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis , 2004, Annals of neurology.

[40]  Toshio Odanaka,et al.  ADAPTIVE CONTROL PROCESSES , 1990 .

[41]  Joseph Parisi,et al.  The pathology of multiple sclerosis. , 2005, Neurologic clinics.

[42]  Jason H. Moore,et al.  Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity , 2003, Genetic epidemiology.

[43]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.